US Patent

US10624855 — Pharmaceutical composition, comprising phosphate binder particles

Formulation · Assigned to Vifor Fresenius Medical Care Renal Pharma Ltd · Expires 2034-11-26 · 9y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a pharmaceutical composition made with specific phosphate binder particles, including sucroferric oxyhydroxide, for a certain particle size distribution.

USPTO Abstract

The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.

Drugs covered by this patent

Patent Metadata

Patent number
US10624855
Jurisdiction
US
Classification
Formulation
Expires
2034-11-26
Drug substance claim
No
Drug product claim
Yes
Assignee
Vifor Fresenius Medical Care Renal Pharma Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.